Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Brazil's agricultural research agency gets cannabis research greenlight - 2Iran-backed Iraqi militias attack Kurdistan over 450 times since beginning of war
- 3Extraordinary Snowboarding Objections All over the Planet
- 4A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests
- 5Noctourism: the new safari travel trend that's changing the wildlife we can photograph in Africa
- Becoming amazing at Arranging Pay Raises
- Top notch DSLR Cameras for Photography Devotees
- Must-See Attractions in Australia
- 6 Monetary Arranging Administrations for Your Necessities
- Dutch police probe a small blast outside a pro-Israel Christian center
- Potential Houthi threat to Red Sea shipping could further damage global economy
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- The 10 Most Famous Style Minutes on Honorary pathway
- Instructions to Keep an Inspirational perspective After Cellular breakdown in the lungs Treatment
